# Association Between Mitral Annular Calcification and Ventricular Tachycardia in Patients with Reduced and Mildly Reduced Ejection Fraction

**Authors:** Müjgan Ayşenur Şahin, Ahmet Seyda Yılmaz, Elif Ergül, Hakan Duman, Hüseyin Durak, Abuzer Duran, Şuayp Osmanoğlu, Mustafa Çetin

PMC · DOI: 10.3390/jcm15031172 · Journal of Clinical Medicine · 2026-02-02

## TL;DR

This study found that mitral annular calcification is strongly linked to ventricular tachycardia in patients with reduced heart function.

## Contribution

The study identifies mitral annular calcification as an independent predictor of ventricular tachycardia in heart failure patients.

## Key findings

- Mitral annular calcification was significantly more common in patients with ventricular tachycardia.
- MAC was the strongest independent predictor of ventricular tachycardia with an odds ratio of 2.74.
- Inflammatory activity, lower albumin, and structural heart parameters were also associated with VT.

## Abstract

Objective: This study aimed to evaluate the association between mitral annular calcification (MAC) and ventricular tachycardia (VT) in patients with reduced and mildly reduced ejection fraction and to identify independent predictors of VT. Materials and Methods: A total of 143 patients with heart failure and left ventricular ejection fraction (LVEF) under 50% were included in this retrospective cross-sectional study. Patients were classified into two groups according to the presence of VT. Clinical, biochemical, and echocardiographic variables were compared between groups. Independent predictors of VT were identified using multivariable logistic regression analysis. Results: MAC was significantly more prevalent in the VT group compared with controls (43.6% vs. 17.4%, p < 0.001) and was the strongest independent predictor of VT (OR: 2.74; 95% CI: 1.13–6.65; p = 0.026). Higher inflammatory activity, lower serum albumin levels, increased left atrial volume, renal dysfunction, and elevated diastolic filling pressures were also associated with VT. Conclusions: MAC is a strong and independent predictor of ventricular tachycardia in patients with reduced and mildly reduced ejection fraction. Incorporating MAC into the overall arrhythmic risk profile alongside inflammatory, metabolic, and structural parameters may improve risk stratification in this population.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), ventricular tachycardia (MONDO:0005477)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** heart failure (MESH:D006333), inflammatory (MESH:D007249), renal dysfunction (MESH:D007674), MAC (MESH:D016460), arrhythmic (OMIM:212500), VT (MESH:D017180)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898176/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898176/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898176/full.md

---
Source: https://tomesphere.com/paper/PMC12898176